Sino-nasal Outcome Test (SNOT22) score in adult population with no known sino-nasal disease.
Quality of life
Rhinology
SNOT-22
Sino-Nasal Outcome Test
Symptom severity
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
23 Mar 2024
23 Mar 2024
Historique:
received:
17
11
2023
accepted:
12
02
2024
medline:
23
3
2024
pubmed:
23
3
2024
entrez:
23
3
2024
Statut:
aheadofprint
Résumé
This cross-sectional study aimed to establish normative values for Sino-Nasal Outcome Test (SNOT-22) score in adult Indian population without known sino-nasal diseases. The purpose was to fill a critical knowledge gap, providing insights into how various host factors influence SNOT-22 scores which seek to serve as reference for clinical studies, facilitating comparisons of symptom severity and aid in patient counselling based on specific score patterns. One thousand and twelve adults meeting inclusion criteria participated in the study. Participants provided demographic information, occupation details, addiction history, and medical background. They completed SNOT-22 questionnaire, grading their symptoms on Likert scale of 0-5 based on severity experienced in the past 2 weeks. The collected data were analysed to derive meaningful insights. Mean SNOT-22 score for the study population was 6.80, with 90% scoring below 15, and 40% within 0-3 range. Females exhibited significantly lower mean scores than males. Residents of rural areas reported higher scores than urban counterparts. Education levels had no significant influence on scores. Occupational exposure to aeroallergens, addiction (especially tobacco), and a history of allergies, bronchial asthma, or atopy were associated with significantly higher SNOT-22 scores. Principal component analysis identified four distinct domains, with the nasal symptom domain consistently emerging as the major contributor to differences in subgroups with significantly different total SNOT-22 scores. The normative data and subgroup analyses established in this study serve as a foundation for future research, aiding clinicians in predicting symptoms and providing tailored counselling for individuals with sino-nasal pathologies.
Identifiants
pubmed: 38520535
doi: 10.1007/s00405-024-08557-5
pii: 10.1007/s00405-024-08557-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 58(Suppl S29):1–464. https://doi.org/10.4193/Rhin20.600
doi: 10.4193/Rhin20.600
pubmed: 32078669
Dejaco D, Riedl D, Huber A et al (2019) The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol 276(5):1355–1365. https://doi.org/10.1007/s00405-019-05320-z
doi: 10.1007/s00405-019-05320-z
pubmed: 30739177
pmcid: 6458972
Ahmadipour Y, Müller O, Kreitschmann-Andermahr I, Mattheis S, Sure U, Hütter BO (2020) Development, reliability, validity and sensitivity of the Sino-Nasal Outcome Test for Neurosurgery (SNOT-NC). Eur Arch Otorhinolaryngol 277(1):235–244. https://doi.org/10.1007/s00405-019-05661-9
doi: 10.1007/s00405-019-05661-9
pubmed: 31559491
Chowdhury NI, Mace JC, Bodner TE et al (2019) Does medical therapy improve sinonasal outcomes test-22 domain scores? An analysis of clinically important differences. Laryngoscope 129(1):31–36. https://doi.org/10.1002/lary.27470
doi: 10.1002/lary.27470
pubmed: 30208209
DeConde AS, Bodner TE, Mace JC, Smith TL (2014) Response shift in quality of life after endoscopic sinus surgery for chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg 140(8):712–719. https://doi.org/10.1001/jamaoto.2014.1045
doi: 10.1001/jamaoto.2014.1045
pubmed: 25074504
pmcid: 4151456
DeConde AS, Mace JC, Bodner T et al (2014) SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis. Int Forum Allergy Rhinol 4(12):972–979. https://doi.org/10.1002/alr.21408
doi: 10.1002/alr.21408
pubmed: 25323055
pmcid: 4260999
Wu D, Gray ST, Holbrook EH, BuSaba NY, Bleier BS (2019) SNOT-22 score patterns strongly negatively predict chronic rhinosinusitis in patients with headache. Int Forum Allergy Rhinol 9(1):9–15. https://doi.org/10.1002/alr.22216
doi: 10.1002/alr.22216
pubmed: 30281928
Gillett S, Hopkins C, Slack R, Browne JP (2009) A pilot study of the SNOT 22 score in adults with no sinonasal disease. Clin Otolaryngol 34(5):467–469. https://doi.org/10.1111/j.1749-4486.2009.01975.x
doi: 10.1111/j.1749-4486.2009.01975.x
pubmed: 19793280
Lange B, Thilsing T, Baelum J, Kjeldsen AD (2016) The Sinonasal Outcome Test 22 score in persons without chronic rhinosinusitis. Clin Otolaryngol 41(2):127–130. https://doi.org/10.1111/coa.12481
doi: 10.1111/coa.12481
pubmed: 26095903
Farhood Z, Schlosser RJ, Pearse ME, Storck KA, Nguyen SA, Soler ZM (2016) Twenty-two-item Sino-Nasal Outcome Test in a control population: a cross-sectional study and systematic review. Int Forum Allergy Rhinol 6(3):271–277. https://doi.org/10.1002/alr.21668
doi: 10.1002/alr.21668
pubmed: 26610073
Erskine SE, Hopkins C, Clark A et al (2017) SNOT-22 in a control population. Clin Otolaryngol 42(1):81–85. https://doi.org/10.1111/coa.12667
doi: 10.1111/coa.12667
pubmed: 27147284
Lachanas VA, Tsea M, Tsiouvaka S, Exarchos ST, Skoulakis CE, Bizakis JG (2015) The effect of active cigarette smoking on Sino-Nasal Outcome Test in 127 subjects without rhinologic disease. A prospective study. Clin Otolaryngol 40(1):56–59. https://doi.org/10.1111/coa.12331
doi: 10.1111/coa.12331
pubmed: 25314243
Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P (2014) Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 348:g1151. https://doi.org/10.1136/bmj.g1151
doi: 10.1136/bmj.g1151
pubmed: 24524926
pmcid: 3923980